EXOME_ID	RNA_ID	FIBROBLAST_ID	TRANSDUCED_GENE	GENOME_ID	PROTEOME_ID	PEDIGREE	DISEASE	KNOWN_MUTATION	VARIANT_EFFECT	CANDIDATE_GENE	BIOCHEMICAL_DEFECT	CLINICAL_SYMPTOMS	CLINICIAN	GENDER	COMMENT	EXOME_ENRICHMENT	GROWTH_MEDIUM	RNA_PERSON	TISSUEEXT_JAP_PT1237	102860	102860				MITO946	MITO					Hyperammonemia	Kei Murayama	male	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT1265	102864	102864				MITO947	MITO					Short stature	Kei Murayama	female	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT1278	102874	102874				MITO948	MITO					Leigh syndrome	Kei Murayama	male	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT1283	102875	102875				MITO949	MITO				I, IV	Leigh syndrome	Kei Murayama	female	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT1297	102876	102876				MITO950	MITO				I, IV		Kei Murayama	male	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT1173	103027	103027				MITO959	MITO				IV		Kei Murayama	female	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT008	103165	103165				MITO964	MITO				I		Kei Murayama	female	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT162	103170	103170				MITO969	MITO		m.12311T>C			Leigh disease	Kei Murayama	male 	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT167	103171	103171				MITO970	MITO				IV		Kei Murayama	female 	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT183	103172	103172				MITO971	MITO						Kei Murayama	male 	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT201	103173	103173				MITO972	MITO					Hepatopathy	Kei Murayama	female	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT284	103174	103174				MITO973	MITO					Short stature	Kei Murayama	male 	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT290	103175	103175				MITO974	MITO					hypertroph restrictive cardiomyopathy	Kei Murayama	female 	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT472	103180	103180				MITO978	MITO				III, IV	Leigh syndrome	Kei Murayama	female 	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT015	103166	103166				MITO965	MITO				I	Leigh syndrome	Kei Murayama	male 	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT487	103182	103182				MITO980	MITO						Kei Murayama	female	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT631	103190	103190				MITO988	MITO				IV	Hepatopathy	Kei Murayama	male	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT639	103192	103192				MITO990	MITO				IV	Leigh syndrome	Kei Murayama	female	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT713	103198	103198				MITO996	MITO					hypertroph restrictive cardiomyopathy	Kei Murayama	male 	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT722	103199	103199				MITO997	MITO					Leigh syndrome	Kei Murayama	female 	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT723	103200	103200				MITO998	MITO				IV	Leigh syndrome	Kei Murayama	female	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT766	103203	103203				MITO1001	MITO				IV	Leigh syndrome	Kei Murayama	male	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT875	103207	103207				MITO1005	MITO					Leigh syndrome	Kei Murayama	female	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT980	103208	103208				MITO1006	MITO				IV	intrauterine growth restriction	Kei Murayama	female	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT947	103209	103209				MITO1007	MITO				I	Leigh syndrome	Kei Murayama	female	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT966	103210	103210				MITO1008	MITO				IV	Leigh syndrome	Kei Murayama	male	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT525	103185	103185				MITO983	MITO				I		Kei Murayama	female	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT984	103213	103213				MITO1011	MITO						Kei Murayama	male	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT1002	103214	103214				MITO1012	MITO			SDHA	II		Kei Murayama	female	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT1009	103216	103216				MITO1014	MITO						Kei Murayama	male 	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT1023	103217	103217				MITO1015	MITO					Hyperammonemia	Kei Murayama	male	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT1050	103219	103219				MITO1017	MITO						Kei Murayama	female	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT1084	103221	103221				MITO1019	MITO						Kei Murayama	female	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT1094	103223	103223				MITO1021	MITO					Mental retardation	Kei Murayama	female	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT1109	103225	103225				MITO1023	MITO					Cardiomyopathy	Kei Murayama	male 	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT1146	103229	103229				MITO1027	MITO			CARS2			Kei Murayama	female	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT1152	103230	103230				MITO1030	MITO			COL1A1	I		Kei Murayama	male	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT1156	103231	103231				MITO1031	MITO			C10orf2		Hepatopathy	Kei Murayama	male	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT1157	103232	103232				MITO1032	MITO						Kei Murayama	female	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT1180	103234	103234				MITO1034	MITO				I	Mental retardation	Kei Murayama	male	Japan cell lines		GLU	AGNIESZKA	fibroblastsEXT_JAP_PT1246	103239	103239				MITO1039	MITO					developmental delay	Kei Murayama	female	Japan cell lines		GLU	AGNIESZKA	fibroblasts104250	104438	104438				MITO_HH008	MITO						Saskia Wortmann 	male	rna-seq repeated, undiagnosed		GLU	AGNIESZKA	fibroblasts	104981	104981				MITO1067	MITO						Saskia Wortmann 		rna-seq repeated, undiagnosed		GLU	AGNIESZKA	fibroblasts87960	104982	104982				SALK0052	MITO					muscular dystrophy 	Johannes Mayr	female	rna-seq repeated, undiagnosed		GLU	AGNIESZKA	fibroblasts95265	105251	105251				ExDiag0648	MITO						Thobias Haack	male	rna-seq repeated, undiagnosed		GLU	AGNIESZKA	fibroblasts106196	105896	105896				MITO_HH012	MITO						Maja Hempel	male	rna-seq repeated, undiagnosed		GLU	AGNIESZKA	fibroblasts34402	106244	106244				MITO1068	MITO						Thomas Klopstock	female	rna-seq repeated, undiagnosed		GLU	AGNIESZKA	fibroblasts																																																																												